These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. Staatz CE; Goodman LK; Tett SE Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406 [TBL] [Abstract][Full Text] [Related]
28. Immunosuppressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat. Moia LJ; Matsui H; de Barros GA; Tomizawa K; Miyamoto K; Kuwata Y; Tokuda M; Itano T; Hatase O Brain Res; 1994 Jun; 648(2):337-41. PubMed ID: 7522929 [TBL] [Abstract][Full Text] [Related]
29. Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture. Norris CM; Blalock EM; Chen KC; Porter NM; Landfield PW Neuroscience; 2002; 110(2):213-25. PubMed ID: 11958864 [TBL] [Abstract][Full Text] [Related]
30. Effects of ciclosporin therapy on xylazine/ketamine anaesthesia in a rat model. Loeffelbein DJ; Nieberler M; Steinstraesser L; Boeckmann R; Hoelzle F; Wolff KD; Kesting MR J Vet Pharmacol Ther; 2010 Feb; 33(1):100-2. PubMed ID: 20444032 [No Abstract] [Full Text] [Related]
31. Regulatory T-Cell Augmentation or Interleukin-17 Inhibition Prevents Calcineurin Inhibitor-Induced Hypertension in Mice. Chiasson VL; Pakanati AR; Hernandez M; Young KJ; Bounds KR; Mitchell BM Hypertension; 2017 Jul; 70(1):183-191. PubMed ID: 28584011 [TBL] [Abstract][Full Text] [Related]
33. Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus. Chakkera HA; Kudva Y; Kaplan B Clin Pharmacol Ther; 2017 Jan; 101(1):114-120. PubMed ID: 27804122 [TBL] [Abstract][Full Text] [Related]
34. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats. Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565 [TBL] [Abstract][Full Text] [Related]
35. Preclinical safety evaluation of inhaled cyclosporine in propylene glycol. Wang T; Noonberg S; Steigerwalt R; Lynch M; Kovelesky RA; Rodríguez CA; Sprugel K; Turner N J Aerosol Med; 2007; 20(4):417-28. PubMed ID: 18158714 [TBL] [Abstract][Full Text] [Related]
37. Tacrolimus and cyclosporine A are of no benefit to young rats with kaolin-induced hydrocephalus. Khan OH; Enno T; Del Bigio MR Pediatr Neurosurg; 2003 Dec; 39(6):309-13. PubMed ID: 14734865 [TBL] [Abstract][Full Text] [Related]
38. Effect of rapamycin in combination with calcineurin inhibitors, FK506 and cyclosporin, following arterial injury. Waller JR; Metcalfe MS; Nicholson ML Transplant Proc; 2002 Aug; 34(5):1481-3. PubMed ID: 12176449 [No Abstract] [Full Text] [Related]
39. Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients. Büchler M; Leibenguth P; Le Guellec C; Carayon A; Watier H; Odoul F; Autret-Leca E; Lebranchu Y; Paintaud G Eur J Clin Pharmacol; 2004 Dec; 60(10):703-8. PubMed ID: 15619133 [TBL] [Abstract][Full Text] [Related]
40. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat. Nielsen FT; Ottosen P; Starklint H; Dieperink H Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]